If you'd invested in: AstraZeneca and Mitie Group
If you'd invested in: AstraZeneca and Mitie Group
Pharmaceutical giant AstraZeneca is expected to grow its earnings, while outsourcer Mitie's share rice has been hit by a series of profit warnings.
10 Aug 2018
How to profit as Britain piles on the pounds
How to profit as Britain piles on the pounds
The world is getting fatter – and with no easy solution to obesity in sight, investing in healthcare providers and food and drink makers could bring b…
28 Sep 2017
Major setback for AstraZeneca
Major setback for AstraZeneca
Pharma giant AstraZeneca was banking on a key clinical trial for its cancer drugs. It was a flop. What comes next? asks Alice Gråhns.
4 Aug 2017
America's clampdown on tax inversions
America's clampdown on tax inversions
The US government has issued new rules making it harder for American companies to cut their tax bill by relocating their headquarters.
25 Sep 2014
A revolutionary new cancer treatment – and the blue-chip stock set to benefit
A revolutionary new cancer treatment – and the blue-chip stock set to benefit
A new kind of cancer therapy could make a big difference to survival rates - and transform the fortunes of one big UK drugs company. Matthew Partridge…
1 Aug 2014
Astra rebuffs 'final' Pfizer bid
Astra rebuffs 'final' Pfizer bid
US drugs giant Pfizer's attempt to takeover AstraZeneca has come to a dead-end.
22 May 2014
AstraZeneca fight rumbles on
AstraZeneca fight rumbles on
The proposed takeover of AstraZeneca is proving to be one of the most controversial yet.
15 May 2014
Get your FREE guide to market crashes
What do past crashes teach us about this one? Subscribe to MoneyWeek now and get a free copy of the Little Book of Big Crashes, plus your first six magazine issues absolutely FREE
How Ian Read launched a raid on Britain’s national champion
How Ian Read launched a raid on Britain’s national champion
As the head of US pharma giant Pfizer, Ian Read has led the takeover bid for Britain's AstraZeneca. But is the British-born boss driven by revenge?
14 May 2014
Company in the news: AstraZeneca
Company in the news: AstraZeneca
Drugs giant AstraZeneca is at the centre of a takeover tussle with US rival Pfizer. Phil Oakley looks at how the shares have been affected.
9 May 2014
Buy Big Pharma – the deal spree could be just beginning
Buy Big Pharma – the deal spree could be just beginning
With pharmaceutical stocks still looking cheap and some very smart deals being done, it’s a good time to buy in to the sector. John Stepek explains ho…
24 Apr 2014